Abstract
Genetics research and innovation have historically faced many technical, legal, and ethical barriers. Although innovation within medical genetics is challenging to quantify, patent data offers a reasonable proxy, given that available diagnostic and therapeutic options generally have associated patents as protection for intellectual property. Here, we conduct an exploratory analysis of genetics-related patents in the United States granted between 2005 and 2020. By exploring the patent landscape, we aim to elucidate trends in genetic innovation that foreshadow updates to clinical practice.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
